Collection 10 May 2023

Disparities in Prostate Cancer Diagnosis and Management

The Editors of Prostate Cancer and Prostatic Diseases (PCAN) are proud to present a special collection on “Disparities in Prostate Cancer Diagnosis and Management”. The collection features papers from recent years by some of the top investigators within the field, highlighting recognized disparities in prostate cancer care, from screening to risk stratification and treatments employed in patient care pathways. This special collection will highlight three topics of particular interest:

Disparities in Prostate Cancer Prognosis
Differences in Genomic Profiling Interpretation
Variable Use of Biomarkers and Imaging

Content

Disparities in prostate cancer diagnosis and management: recognizing that disparities exist at all junctures along the prostate cancer journey
- Soroush Rais-Bahrami
- Yao Zhu
Editorial28 Apr 2023 Prostate Cancer and Prostatic Diseases
Race-dependent association of clinical trial participation with improved outcomes for high-risk prostate cancer patients treated in the modern era
- Ting Martin Ma
- Felix Y. Feng
- Amar U. Kishan
Brief Communication25 Mar 2023 Prostate Cancer and Prostatic Diseases
Trends in prostate cancer mortality in the United States of America, by state and race, from 1999 to 2019: estimates from the centers for disease control WONDER database
- Chinmay Jani
- Christian Mouchati
- Rana R. McKay
Article16 Dec 2022 Prostate Cancer and Prostatic Diseases
Ethnic differences in prostate-specific antigen levels in men without prostate cancer: a systematic review
- Melissa Barlow
- Liz Down
- Sarah Elizabeth Rose Bailey
Review ArticleOpen Access1 Dec 2022 Prostate Cancer and Prostatic Diseases
Substantial Gleason reclassification in Black men with national comprehensive cancer network low-risk prostate cancer – A propensity score analysis
- Shivanshu Awasthi
- Brandon A. Mahal
- Kosj Yamoah
Article23 Feb 2022 Prostate Cancer and Prostatic Diseases
The effect of race on treatment patterns and subsequent health-related quality of life outcomes in men undergoing treatment for localized prostate cancer
- Natasza M. Posielski
- Santosh Shanmuga
- Christopher Porter
Article10 Nov 2022 Prostate Cancer and Prostatic Diseases
Prostate-specific antigen response and clinical progression-free survival in Black and White men with chemotherapy-naïve metastatic castration-resistant prostate cancer treated with enzalutamide in a real-world setting
- Stephen J. Freedland
- Agnes Hong
- Alicia K. Morgans
ArticleOpen Access14 Dec 2022 Prostate Cancer and Prostatic Diseases
Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registry
- Oliver Sartor
- Andrew J. Armstrong
- Celestia S. Higano
ArticleOpen Access28 Feb 2020 Prostate Cancer and Prostatic Diseases
Race reporting and diversity in US food and drug administration (FDA) registration trials for prostate cancer; 2006–2020
- M. P. Lythgoe
- J. Krell
- V. Prasad
Brief CommunicationOpen Access15 Apr 2021 Prostate Cancer and Prostatic Diseases
Evaluation of the contribution of demographics, access to health care, treatment, and tumor characteristics to racial differences in survival of advanced prostate cancer
- Marieke J. Krimphove
- Alexander P. Cole
- Quoc-Dien Trinh
Article31 Aug 2018 Prostate Cancer and Prostatic Diseases
Increased frequency of germline BRCA2 mutations associates with prostate cancer metastasis in a racially diverse patient population
- Gyorgy Petrovics
- Douglas K. Price
- Michael Dean
ArticleOpen Access12 Dec 2018 Prostate Cancer and Prostatic Diseases
Germline alterations among Hispanic men with prostate cancer
- Elizabeth Pan
- Justin Shaya
- Rana R. McKay
Article28 Feb 2022 Prostate Cancer and Prostatic Diseases
Validation of a genomic classifier for prediction of metastasis and prostate cancer-specific mortality in African-American men following radical prostatectomy in an equal access healthcare setting
- Lauren E. Howard
- Jingbin Zhang
- Stephen J. Freedland
Article16 Dec 2019 Prostate Cancer and Prostatic Diseases
Racial disparity in the utilization of multiparametric MRI–ultrasound fusion biopsy for the detection of prostate cancer
- Connor Hoge
- Sadhna Verma
- Abhinav Sidana
Article9 Mar 2020 Prostate Cancer and Prostatic Diseases
Ethnic variation in prostate cancer detection: a feasibility study for use of the Stockholm3 test in a multiethnic U.S. cohort
- Hari T. Vigneswaran
- Andrea Discacciati
- Michael R. Abern
Article8 Jul 2020 Prostate Cancer and Prostatic Diseases
Race and prostate specific antigen surveillance testing and monitoring 5-years after definitive therapy for localized prostate cancer
- Ibrahim M. Asiri
- Ronald C. Chen
- Ewan K. Cobran
Article3 May 2021 Prostate Cancer and Prostatic Diseases

Disparities in Prostate Cancer Diagnosis and Management

Content

Disparities in prostate cancer diagnosis and management: recognizing that disparities exist at all junctures along the prostate cancer journey

Race-dependent association of clinical trial participation with improved outcomes for high-risk prostate cancer patients treated in the modern era

Trends in prostate cancer mortality in the United States of America, by state and race, from 1999 to 2019: estimates from the centers for disease control WONDER database

Ethnic differences in prostate-specific antigen levels in men without prostate cancer: a systematic review

Substantial Gleason reclassification in Black men with national comprehensive cancer network low-risk prostate cancer – A propensity score analysis

The effect of race on treatment patterns and subsequent health-related quality of life outcomes in men undergoing treatment for localized prostate cancer

Prostate-specific antigen response and clinical progression-free survival in Black and White men with chemotherapy-naïve metastatic castration-resistant prostate cancer treated with enzalutamide in a real-world setting

Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registry

Race reporting and diversity in US food and drug administration (FDA) registration trials for prostate cancer; 2006–2020

Evaluation of the contribution of demographics, access to health care, treatment, and tumor characteristics to racial differences in survival of advanced prostate cancer

Increased frequency of germline BRCA2 mutations associates with prostate cancer metastasis in a racially diverse patient population

Germline alterations among Hispanic men with prostate cancer

Validation of a genomic classifier for prediction of metastasis and prostate cancer-specific mortality in African-American men following radical prostatectomy in an equal access healthcare setting

Racial disparity in the utilization of multiparametric MRI–ultrasound fusion biopsy for the detection of prostate cancer

Ethnic variation in prostate cancer detection: a feasibility study for use of the Stockholm3 test in a multiethnic U.S. cohort

Race and prostate specific antigen surveillance testing and monitoring 5-years after definitive therapy for localized prostate cancer

Search

Quick links